Globus Medical (GMED) Reiterated at Market Perform by Citizens After Q1 Results
Citizens analyst David Turkaly reiterated a Market Perform rating on Globus Medical (NYSE: GMED).The analyst commented, "We reiterate our Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
